Exact Mass: 306.1175438
Exact Mass Matches: 306.1175438
Found 500 metabolites which its exact mass value is equals to given mass value 306.1175438,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cimitin
Cimifugin is an oxacycle and an organic heterotricyclic compound. Cimifugin is a natural product found in Eranthis cilicica, Ostericum grosseserratum, and other organisms with data available. Cimifugin (Cimitin) is a bioactive component of Cimicifuga racemosa, a Chinese herb. Cimifugin suppresses allergic inflammation by reducing epithelial derived initiative key factors via regulating tight junctions[1]. Cimifugin reduces the migration and chemotaxis of RAW264.7 cells and inhibits the release of inflammatory factors and activation of MAPKs and NF-κB signaling pathways induced by LPS[2]. Cimifugin (Cimitin) is a bioactive component of Cimicifuga racemosa, a Chinese herb. Cimifugin suppresses allergic inflammation by reducing epithelial derived initiative key factors via regulating tight junctions[1]. Cimifugin reduces the migration and chemotaxis of RAW264.7 cells and inhibits the release of inflammatory factors and activation of MAPKs and NF-κB signaling pathways induced by LPS[2].
Fluconazole
C13H12F2N6O (306.10406059999997)
Fluconazole is only found in individuals that have used or taken this drug. It is a triazole antifungal agent that is used to treat oropharyngeal candidiasis and cryptococcal meningitis in AIDS. [PubChem]Fluconazole interacts with 14-α demethylase, a cytochrome P-450 enzyme necessary to convert lanosterol to ergosterol. As ergosterol is an essential component of the fungal cell membrane, inhibition of its synthesis results in increased cellular permeability causing leakage of cellular contents. Fluconazole may also inhibit endogenous respiration, interact with membrane phospholipids, inhibit the transformation of yeasts to mycelial forms, inhibit purine uptake, and impair triglyceride and/or phospholipid biosynthesis. J - Antiinfectives for systemic use > J02 - Antimycotics for systemic use > J02A - Antimycotics for systemic use > J02AC - Triazole and tetrazole derivatives D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use > D01AC - Imidazole and triazole derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065689 - Cytochrome P-450 CYP2C19 Inhibitors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065688 - Cytochrome P-450 CYP2C9 Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058888 - 14-alpha Demethylase Inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Z-Gly-Pro
KEIO_ID Z003; [MS3] KO009084 KEIO_ID Z003; [MS2] KO009083 KEIO_ID Z003
(1aalpha,2beta,3alpha,11calpha)-1a,2,3,11c-Tetrahydro-6,11-dimethylbenzo[6,7]phenanthro[3,4-b]oxirene-2,3-diol
(1aalpha,2beta,3alpha,11calpha)-1a,2,3,11c-Tetrahydro-6,11-dimethylbenzo[6,7]phenanthro[3,4-b]oxirene-2,3-diol is considered to be practically insoluble (in water) and relatively neutral
Glutathione amide
The dicarboxylic acid monoamide arising by formal condensation of the carboxylic acid group of the glycine residue of glutathione with ammonia.
3-Oxo-14,15-dehydrorhazinilam
3-Oxo-14,15-dehydrorhazinilam is an alkaloid from Aspidosperma quebracho-blanco (quebracho). Alkaloid from Aspidosperma quebracho-blanco (quebracho)
Nb-p-Coumaroyltryptamine
Nb-p-Coumaroyltryptamine is found in cereals and cereal products. Nb-p-Coumaroyltryptamine is found in kernels of sweet corn (Zea mays). Found in kernels of sweet corn (Zea mays)
trans-O-Methylgrandmarin
trans-O-Methylgrandmarin is found in citrus. trans-O-Methylgrandmarin is a constituent of satsuma mandarins (Citrus unshiu). Constituent of satsuma mandarins (Citrus unshiu). trans-O-Methylgrandmarin is found in citrus.
O-Isopentenylhalfordinol
O-Isopentenylhalfordinol is found in fruits. O-Isopentenylhalfordinol is an alkaloid from Aegle marmelos (bael fruit
2,5-Dibenzyl-3-hydroxy-6-methoxypyrazine
2,5-Dibenzyl-3-hydroxy-6-methoxypyrazine is found in mushrooms. 2,5-Dibenzyl-3-hydroxy-6-methoxypyrazine is isolated from fruiting bodies of the mushroom Albatrellus confluens (edibility unknown). Isolated from fruiting bodies of the mushroom Albatrellus confluens (edibility unknown). 2,5-Dibenzyl-3-hydroxy-6-methoxypyrazine is found in mushrooms.
6-O-Desmethyl-mycophenolic acid
6-O-Desmethyl-mycophenolic acid is a metabolite of mycophenolic acid. Mycophenolic acid or mycophenolate is an immunosuppressant drug used to prevent rejection in organ transplantation. It inhibits an enzyme needed for the growth of T cells and B cells. It was initially marketed as the prodrug mycophenolate mofetil (MMF) to improve oral bioavailability. More recently, the salt mycophenolate sodium has also been introduced. Mycophenolic acid is commonly marketed under the trade names CellCept and Myfortic. (Wikipedia)
(+/-)-(e)-4-Ethyl-2-[(z)-hydroxyimino]-5-nitro-3-hexen-1-yl-nicotinamide
2-Hydroxy-1-naphthaldehyde salicyloylhydrazone
C18H14N2O3 (306.10043740000003)
Propylenediamine tetra-acetic acid
Cimifugin
Metioprim
C14H18N4O2S (306.11504080000003)
C254 - Anti-Infective Agent > C258 - Antibiotic
Quinocetone
C18H14N2O3 (306.10043740000003)
(1Z,3E)-14-Acetoxy-1-chlorohexadeca-1,3-diene-5,7-diyne
5-(Hydroxymethyl)-6-(3,5-dimethoxy-4-hydroxyphenyl)-8-oxabicyclo[3.2.1]octa-3-ene-2-one
1-(4-methoxyphenyl)-3-(thiomorpholin-4-yl)pyrrolidine-2,5-dione
N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-3-phenyl-2-propenamide
7-(3-Methylbut-2-enyloxy)flavone|7-(3-methyl-but-2-enyloxy)-2-phenyl-chromen-4-one|7-gamma,gamma-dimethylallyloxyflavanone|Cordoin-flavon
2-bromo-2,6,10-trimethylundecanoic acid
C14H27BrO2 (306.11943019999995)
8alpha-acetoxy-3alpha,4alpha-epoxy-1alpha-hydroxyguai-9,11(13)-dien-6alpha,12-olide
1,7,8,9-Tetrahydro-1,9-dihydroxy-4-methoxy-5-methyl-8-(1-methylethenyl)-3H-furo[3,4-f][1]benzopyran-3-one
(2S)-5-hydroxy-2-(1-hydroxy-4-oxocyclohexyl)-7-methoxychroman-4-one|(2S)-ongokein-4-one
(2E,6E)-8-(2,4,5-trihydroxyphenyl)-2,6-dimethyl-8-oxo-2,6-dienoic acid|orirubenone B
Methyl 5-acetoxymethanol-7-hydroxy-2,2-dimethyl-2H-1-chromene-6-carboxylate|methyl 5-acetoxymethyl-7-hydroxy-2,2-dimethyl-2H-1-chromene-6-carboxylate
plectranthon A|Plectranthon A ( = 3-Hydroxy-5,7,8-trimethyl-2-(prop-2-enyl)phenanthren-1,4-dion)|Plectranthone A
1,4,6-trihydroxy-2-methoxy-7-methyl-5,6,8,8a,9,10a-hexahydro-7,9-epoxyanthracen-10-one|fusaquinon A
2,3-Dihydro-3,9-dihydroxy-4-phenyl-5-methoxy-1H-phenalene
plectranthon D|Pseudoplectranthon D ( = 3-Hydroxy-7,8,10-trimethyl-2-(prop-2-enyl)phenanthren-1,4-dion)
(E)-1-(5-hydroxy-2,2-dimethyl-2H-chromen-6-yl)-3-phenylprop-2-en-1-one|1-(5-Hydroxy-2,2-dimethyl-2H-chromen-6-yl)-3t-phenyl-propenon|1-(5-hydroxy-2,2-dimethyl-2H-chromen-6-yl)-3t-phenyl-propenone|Lonchocarpin|lonchocarpine
(-)-erythro-6-(1,2-dihydroxy-3-methylbut-3-enyl)-7,8-dimethoxy-[2H]-chromen-2-one|(-)-fatouain A
6-Oxo-6H-3,6a-diazafluoranthene-4-butanoic acid
C18H14N2O3 (306.10043740000003)
16alpha-Chloro-17alpha-estradiol|16beta-Chloro-17alpha-estradiol
nigerapyrone A
A member of the class of 2-pyranones that is 2H-pyran-2-one substituted by a methoxy group at position 4 and a 4,6-dimethylbiphenyl-2-yl group at position 6. It has been isolated from an endophytic fungus, Aspergillus niger.
3-hydroxy-1-keto-3-methyl-8-methoxy-1,2,3, 4-tetrahydro-benz[alpha]anthracene
(+)-(S)-2-{7-[1-(4-hydroxyphenyl)ethyl]-4-methoxy-1H-indol-3-yl}acetonitrile
(+)-fatouain E|(+)-threo-8-hydroxy-6-(2-hydroxy-1-methoxy-3-methylbut-3-enyl)-7-methoxy-[2H]-chromen-2-one
6-(2,3-Dihydroxy-3-methylbutyl)-7-acetoxy-2H-1-benzopyran-2-one
(S)-2,5,7-trihydroxy-3-(5-hydroxyhexyl)-1,4-naphthoquinone
(1R)-2,3-dihydro-4,9-dihydroxy-8-methoxy-1-phenylphenalene|2,3-dihydro-4,9-dihydroxy-8-methoxy-1-phenylphenalene
(Z)-6-benzylidene-3-hydroxymethyl-1,4-dimethyl-3-methylsulfanylpiperazine-2,5-dione
3-(5-(4-(3-Methylbut-3-enoxy)phenyl)-1,3-oxazol-2-yl)pyridine
2-(2-Hydroxypentyl)-4-oxo-7-methoxy-4H-1-benzopyran-5-carboxylic acid
(+/-)-6-(1-ethoxyethyl)-5-hydroxy-2,7-dimethoxynaphthoquinone|6-(1-Ethoxyethyl)-5-hydroxy-2,7-dimethoxy-1,4-naphthoquinone
2-(hydroxymethyl)-6-naphthalen-2-yloxyoxane-3,4,5-triol
fluconazole
C13H12F2N6O (306.10406059999997)
J - Antiinfectives for systemic use > J02 - Antimycotics for systemic use > J02A - Antimycotics for systemic use > J02AC - Triazole and tetrazole derivatives D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use > D01AC - Imidazole and triazole derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065689 - Cytochrome P-450 CYP2C19 Inhibitors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065688 - Cytochrome P-450 CYP2C9 Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058888 - 14-alpha Demethylase Inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 542; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3238; ORIGINAL_PRECURSOR_SCAN_NO 3236 CONFIDENCE standard compound; INTERNAL_ID 542; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3247; ORIGINAL_PRECURSOR_SCAN_NO 3245 CONFIDENCE standard compound; INTERNAL_ID 542; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3228; ORIGINAL_PRECURSOR_SCAN_NO 3225 CONFIDENCE standard compound; INTERNAL_ID 542; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3241; ORIGINAL_PRECURSOR_SCAN_NO 3237 CONFIDENCE standard compound; INTERNAL_ID 542; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3236; ORIGINAL_PRECURSOR_SCAN_NO 3231 CONFIDENCE standard compound; INTERNAL_ID 542; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3230; ORIGINAL_PRECURSOR_SCAN_NO 3229 CONFIDENCE standard compound; INTERNAL_ID 542; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6761; ORIGINAL_PRECURSOR_SCAN_NO 6759 CONFIDENCE standard compound; INTERNAL_ID 542; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6801; ORIGINAL_PRECURSOR_SCAN_NO 6798 CONFIDENCE standard compound; INTERNAL_ID 542; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6803; ORIGINAL_PRECURSOR_SCAN_NO 6800 CONFIDENCE standard compound; INTERNAL_ID 542; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6824; ORIGINAL_PRECURSOR_SCAN_NO 6823 CONFIDENCE standard compound; INTERNAL_ID 542; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6831; ORIGINAL_PRECURSOR_SCAN_NO 6829 CONFIDENCE standard compound; INTERNAL_ID 542; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6836; ORIGINAL_PRECURSOR_SCAN_NO 6832 CONFIDENCE standard compound; INTERNAL_ID 2352 CONFIDENCE Parent Substance (Level 1); INTERNAL_ID 2300 CONFIDENCE standard compound; INTERNAL_ID 8598 INTERNAL_ID 8598; CONFIDENCE standard compound CONFIDENCE standard compound; EAWAG_UCHEM_ID 328 EAWAG_UCHEM_ID 328; CONFIDENCE standard compound
5-(3-hydroxy-4,5-dimethoxyphenyl)-2,3-dimethoxyphenol
(E)-1-(5-hydroxy-2,2-dimethylchromen-6-yl)-3-phenylprop-2-en-1-one
Cimifugin
Cimifugin (Cimitin) is a bioactive component of Cimicifuga racemosa, a Chinese herb. Cimifugin suppresses allergic inflammation by reducing epithelial derived initiative key factors via regulating tight junctions[1]. Cimifugin reduces the migration and chemotaxis of RAW264.7 cells and inhibits the release of inflammatory factors and activation of MAPKs and NF-κB signaling pathways induced by LPS[2]. Cimifugin (Cimitin) is a bioactive component of Cimicifuga racemosa, a Chinese herb. Cimifugin suppresses allergic inflammation by reducing epithelial derived initiative key factors via regulating tight junctions[1]. Cimifugin reduces the migration and chemotaxis of RAW264.7 cells and inhibits the release of inflammatory factors and activation of MAPKs and NF-κB signaling pathways induced by LPS[2].
C16H18O6_3H-Oxireno[h][3]benzoxacyclododecin-7,13(2H,8H)-dione, 1a,4,5,13a-tetrahydro-10,12-dihydroxy-5-methyl
C19H18N2O2_3,3-Di(1H-indol-3-yl)-1,2-propanediol
15,17-dihydroxy-9-methyl-4,10-dioxatricyclo[11.4.0.0³,⁵]heptadeca-1(17),13,15-triene-2,11-dione
15,17-dihydroxy-9-methyl-4,10-dioxatricyclo[11.4.0.0³,⁵]heptadeca-1(17),13,15-triene-2,11-dione_major
15,17-dihydroxy-9-methyl-4,10-dioxatricyclo[11.4.0.0³,?]heptadeca-1(17),13,15-triene-2,11-dione
Gly Gly Ser Ser
Gly Ser Gly Ser
Gly Ser Ser Gly
Ser Gly Gly Ser
Ser Gly Ser Gly
Ser Ser Gly Gly
trans-O-Methylgrandmarin
AQC-3
11-dimethylarsinoyl-undecanoic acid
C13H27O3As (306.11760519999996)
N-(4-amino-2-methoxy-5-methylphenyl)-4-methylbenzenesulfonamide
3-AMINO-8-BENZYL-8-AZABICYCLO[3.2.1]OCTANE DIHYDROCHLORIDE MONOHYDRATE (3-ENDO)-
C14H24Cl2N2O (306.12655939999996)
2-[4-(ACETYLAMINO)PHENYL]QUINOLINE-4-CARBOXYLIC ACID
C18H14N2O3 (306.10043740000003)
(1-{[(2-Methyl-2-propanyl)oxy]carbonyl}-5-nitro-1H-indol-2-yl)bor onic acid
ethyl 4-hydroxy-5,6,8-trimethoxynaphthalene-2-carboxylate
METHYL-1-PHENETHYL-5-PHENYLIMIDAZOLE-4-CARBOXYLATE
Potassium (4-tert-butoxycarbonylpiperazin-1-yl)methyltrifluoroborate
Dodecanoic acid,2-bromo-, ethyl ester
C14H27BrO2 (306.11943019999995)
1-[2-(4-methoxyphenyl)ethyl]piperidin-4-amine,dihydrochloride
C14H24Cl2N2O (306.12655939999996)
1,3-bis(3-carboxypropyl)tetramethyldisiloxane
C12H26O5Si2 (306.13187059999996)
7-Hydroxy-6-methoxy-3-[(pivaloyloxy)methyl]-3,4-dihydroquinazolin-4-one
1,3-BIS-(2,3-DIHYDRO-INDOL-1-YL)-PROPANE-1,3-DIONE
4-((4-Methylpiperazin-1-yl)Methyl)phenylboronic acid
3-hydroxy-N-(phenylcarbamoyl)naphthalene-2-carboxamide
C18H14N2O3 (306.10043740000003)
1,1,3,3-Tetraethoxy-1,3-divinyldisiloxane
C12H26O5Si2 (306.13187059999996)
3-methoxy-6-methyl-1-(3,4,5-trimethoxyphenyl)pyridazin-4-one
2-(9-BROMONONYL-1-OXY)TETRAHYDROPYRAN
C14H27BrO2 (306.11943019999995)
1H-PYRAZOLE-4-CARBOXYLIC ACID, 5-METHYL-1,3-DIPHENYL-, ETHYL ESTER
4-[5-(4-ISOBUTYL-PHENYL)-[1,2,4]OXADIAZOL-3-YL]-BENZALDEHYDE
6-(Benzyloxy)-4-hydroxy-7-methoxy-3-quinolinecarbonitrile
C18H14N2O3 (306.10043740000003)
4-(2-methoxyphenoxy)-N-(pyridin-3-ylmethyl)aniline
N-(4-Nitro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide
Ethyl 4-hydroxy-1-(2-methoxyethyl)-7-methyl-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxylate
4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid
N-(3-PHENYL-4,5,6,7-TETRAHYDROBENZO[D]THIAZOL-2(3H)-YLIDENE)ANILINE
C19H18N2S (306.11906280000005)
5-(N-TERT-BUTOXYCARBONYLAMINOMETHYL)-4-PHENYL-1,2,4-TRIAZOLE-3-THIOL
C14H18N4O2S (306.11504080000003)
L-Proline 4-methoxy-β-naphthylamide hydrochloride
C16H19ClN2O2 (306.11349839999997)
4-(5-cyano-7-isopropylbenzo[d]oxazol-2-yl)benzoic acid
C18H14N2O3 (306.10043740000003)
2-BENZYL-1,2,3,6,7,11B-HEXAHYDRO-4H-PYRAZION[2,1-A]ISOQUINOLINE-4-ONE
[5,5-Biisobenzofuran]-1,1,3,3-tetrone, dodecahydro-
(2R,5S)-5-Benzyl-3-methyl-2-(5-methylfuran-2-yl)imidazolidin-4-one Hydrochloride
C16H19ClN2O2 (306.11349839999997)
(3-((TERT-BUTYLDIMETHYLSILYL)OXY)-2,4,6-TRIFLUOROPHENYL)BORONIC ACID
C12H18BF3O3Si (306.10703040000004)
3-(2-PHENOXYPHENYL)PROPANOIC ACID
C14H18N4O2S (306.11504080000003)
7-(Benzyloxy)-4-hydroxy-6-methoxy-3-quinolinecarbonitrile
C18H14N2O3 (306.10043740000003)
4H-1,4-BENZODIAZEPINE-4,8-DICARBOXYLIC ACID-1,2,3,5-TETRAHYDRO-2-OXO-4-(1,1-DIMETHYLETHYL) ESTER
1-(5-Tert-butyl-2-methyl-2H-pyrazol-3-YL)-3-(4-chloro-phenyl)-urea
(S)-2-Amino-3-(p-hydroxyphenyl)-N-(2-naphthyl)propionamide
N-cyano-N-propan-2-ylcarbamimidothioic acid [2-(2-methoxyanilino)-2-oxoethyl] ester
C14H18N4O2S (306.11504080000003)
Metioprim
C14H18N4O2S (306.11504080000003)
C254 - Anti-Infective Agent > C258 - Antibiotic
15,17-Dihydroxy-9-methyl-4,10-dioxatricyclo[11.4.0.03,5]heptadeca-1(13),14,16-triene-2,11-dione
N-[(4S)-4-azaniumyl-4-carboxylatobutanoyl]-L-cysteinylglycinamide
(2S)-2-[2-[[(4R)-4-amino-4-carboxybutyl]amino]-2-oxoethyl]-2-hydroxybutanedioic acid
2-[2-[3-[Acetyl(hydroxy)amino]propylamino]-2-oxoethyl]-2-hydroxybutanedioic acid
(+/-)-(e)-4-Ethyl-2-[(z)-hydroxyimino]-5-nitro-3-hexen-1-yl-nicotinamide
1-(3-Ethylphenyl)-3-(1-naphthalenyl)thiourea
C19H18N2S (306.11906280000005)
4-(4-nitrophenyl)-N-prop-2-enyl-1-piperazinecarbothioamide
C14H18N4O2S (306.11504080000003)
Ethyl 4-(3-methoxyphenyl)-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate
3-(1-Benzimidazolyl)-6-ethyl-7-hydroxy-1-benzopyran-4-one
C18H14N2O3 (306.10043740000003)
2-methoxy-5-propan-2-yl-N-(2-pyridinyl)benzenesulfonamide
N-[4-[2-(2-methoxyethylamino)-6H-1,3,4-thiadiazin-5-yl]phenyl]acetamide
C14H18N4O2S (306.11504080000003)
4-[(3-Cyano-4,6-dimethyl-2-pyridinyl)thio]-3-oxobutanoic acid propan-2-yl ester
1-(2,3-Dihydroindol-1-yl)-2-(5-pyridin-4-yl-2-tetrazolyl)ethanone
2-(1,3-benzodioxol-5-yl)-N-(3-pyridinylmethyl)-4-pyrimidinamine
1-Chloro-2-[2-(2-methoxy-4-methylphenoxy)ethoxy]-4-methylbenzene
C17H19ClO3 (306.10226539999996)
2,3-Dihydroindol-1-yl-(6-fluoro-2-methyl-4-quinolinyl)methanone
C19H15FN2O (306.11683519999997)
2-(2-furanyl)-5-methyl-6-(phenylmethyl)-1H-[1,2,4]triazolo[1,5-a]pyrimidin-7-one
3-(4-Fluorophenyl)-5-(2-furanyl)-2-phenyl-3,4-dihydropyrazole
C19H15FN2O (306.11683519999997)
(3S)-4-oxo-3-phenyl-3-propan-2-yldiazetidine-1,2-dicarboxylic acid dimethyl ester
5-(3-Hydroxy-4,5-dimethoxyphenyl)-2,3-dimethoxyphenol
(2R)-2-[4-(1H-indol-3-yl)butanoylamino]-3-sulfanylpropanoic acid
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2,6-dimethyl-4-quinolinamine
8-(3-Phenylpropenoyl)-2,2-dimethyl-2H-1-benzopyran-7-ol
(2S,3R,4S)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C19H15FN2O (306.11683519999997)
(2S,3S,4S)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C19H15FN2O (306.11683519999997)
(2S,3S,4R)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)azetidine-2-carbonitrile
C19H15FN2O (306.11683519999997)
(2R,3R,4S)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C19H15FN2O (306.11683519999997)
2-[(2R,3R,6S)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid
(2R,3S,4R)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C19H15FN2O (306.11683519999997)
2-[(2S,3R,6S)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid
2-[(2R,3S,6R)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid
2-[(2S,3S,6R)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid
2-[(2S,3S,6S)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid
2-[(2R,3R,6R)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid
(2S,3R,4R)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C19H15FN2O (306.11683519999997)
(2R,3R,4R)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C19H15FN2O (306.11683519999997)
1-(4-Chlorophenyl)-2-[5-(1-pyrrolidinyl)-2-tetrazolyl]ethanone oxime
5-[(S)-alpha-Hydroxy 3,4,5-trimethoxybenzyl]-2,4-pyrimidinediamine
2-amino-7-[4-hydroxy-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-4-oxo-3H-pyrrolo[2,3-d]pyrimidine-5-carboximidamide
1-[(E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enylidene]pyrrolidin-1-ium-2-carboxylic acid
2-(4-Methylphenyl)-5-phenyltetrahydropyrrolo[3,4-c]pyrrole-1,3(2H,5H)-dione
(1aalpha,2beta,3alpha,11calpha)-1a,2,3,11c-Tetrahydro-6,11-dimethylbenzo[6,7]phenanthro[3,4-b]oxirene-2,3-diol
1-naphthyl beta-D-glucoside
A beta-D-glucoside that is beta-D-glucopyranose in which the anomeric hydroxy hydrogen has been replaced by a 1-naphthyl group.
Pyridine, 3-[5-[4-[(3-methyl-2-butenyl)oxy]phenyl]-2-oxazolyl]-
glutathione amide zwitterion
Zwitterionic form of glutathione amide having an anionic carboxy group and a protonated amino group; major species at pH 7.3.
Facinicline (hydrochloride)
Facinicline hydrochloride (RG3487 hydrochloride) is an orally active nicotinic α7 receptor partial agonist, with a Ki of 6 nM for α7 human nAChR. Facinicline hydrochloride (RG3487 hydrochloride) improves cognition and sensorimotor gating in rodents. Facinicline hydrochloride (RG3487 hydrochloride) shows high affinity (antagonist) to 5-HT3Rs with a Ki value of 1.2 nM[1].
ML353
C19H15FN2O (306.11683519999997)
ML353 is a selective ligand of mGlu5 silent allosteric modulator (SAM) with an Ki value of 18.2 nM. ML353 improves the affinity of common allosteric sites, 20-fold higher than the previous mGlu5 SAM tool compound 5mpep. ML353 has potential applications in solving the intrinsic activity of SAM in vivo or as a agent blocker[1]. ML353 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
10-hydroxy-9-methyl-5-methylidene-4-oxo-3,13-dioxatetracyclo[8.4.0.0²,⁶.0¹²,¹⁴]tetradec-8-en-7-yl acetate
(5z)-3-benzyl-1-hydroxy-5-(phenylmethylidene)pyrazine-2,6-dione
C18H14N2O3 (306.10043740000003)
9-hydroxy-5,10-dimethoxy-8,8-dimethyl-9h,10h-pyrano[2,3-h]chromen-2-one
5-hydroxy-3-[(2s)-2-hydroxypropyl]-6,8-dimethoxy-2-methylnaphthalene-1,4-dione
(3s,12s,13s)-3,13-dihydroxy-7-methoxy-8-methyl-12-(prop-1-en-2-yl)-4,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-trien-5-one
2-(1,4-dihydroxycyclohexyl)-5-hydroxy-7-methoxychromen-4-one
(1s,2s,4s,5s,6r,10r)-10-hydroxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.0²,⁴]decan-5-yl benzoate
3-[2-(2,5-dihydroxyphenyl)-2-oxoethyl]-3-hydroxy-6-(prop-1-en-2-yl)oxan-2-one
[(5s)-5-[(2r)-2-methoxy-5-oxopyrrolidin-1-yl]-2,5-dihydrofuran-3-yl]methyl 1h-pyrrole-2-carboxylate
(1s,2s,6r,7s,10s,12r,14s)-10-hydroxy-9-methyl-5-methylidene-4-oxo-3,13-dioxatetracyclo[8.4.0.0²,⁶.0¹²,¹⁴]tetradec-8-en-7-yl acetate
(3r,13e,15z)-16-chlorohexadeca-13,15-dien-9,11-diyn-3-yl acetate
(3r,3ar,4r,6s)-3-(furan-3-yl)-6-hydroxy-3a,7-dimethyl-1-oxo-3,4,5,6-tetrahydro-2-benzofuran-4-yl acetate
(9r,10s)-9-hydroxy-5,10-dimethoxy-8,8-dimethyl-9h,10h-pyrano[2,3-h]chromen-2-one
16-amino-14,15-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,9(17),10,12,14-octaen-8-one
C18H14N2O3 (306.10043740000003)
(3s,5r,9s)-15,17-dihydroxy-9-methyl-4,10-dioxatricyclo[11.4.0.0³,⁵]heptadeca-1(17),13,15-triene-2,11-dione
3-benzyl-5-hydroxy-1-methyl-6-(phenylmethylidene)-3h-pyrazin-2-one
7-[(1s)-1-hydroxypropyl]-8-methyl-11h-indolizino[1,2-b]quinolin-9-one
1-(5-hydroxy-2,2-dimethylchromen-6-yl)-3-phenylprop-2-en-1-one
methyl 2-[(4s,6s,9z,10r)-6-methyl-8,12-dioxo-5,11-dioxatricyclo[8.2.1.0⁴,⁶]tridec-1(13)-en-9-ylidene]propanoate
3-(furan-3-yl)-6-hydroxy-3a,7-dimethyl-1-oxo-3,4,5,6-tetrahydro-2-benzofuran-4-yl acetate
1-naphthol-β-d-glucopyranoside
{"Ingredient_id": "HBIN002826","Ingredient_name": "1-naphthol-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C16H18O6","Ingredient_Smile": "C1=CC=C2C(=C1)C=CC=C2OC3C(C(C(C(O3)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "15246","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(2s)-ongokein-4'-one
{"Ingredient_id": "HBIN006819","Ingredient_name": "(2s)-ongokein-4'-one","Alias": "NA","Ingredient_formula": "C16H18O6","Ingredient_Smile": "COC1=CC(=C2C(=O)CC(OC2=C1)C3(CCC(=O)CC3)O)O","Ingredient_weight": "306.31 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16087","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101763963","DrugBank_id": "NA"}
6-(2',3'-dihydroxy-3'-methylbutyl)-7-acetoxy-2h-1-benzopyran-2-one
{"Ingredient_id": "HBIN012009","Ingredient_name": "6-(2',3'-dihydroxy-3'-methylbutyl)-7-acetoxy-2h-1-benzopyran-2-one","Alias": "NA","Ingredient_formula": "C16H18O6","Ingredient_Smile": "CC(=O)OC1=C(C=C2C=CC(=O)OC2=C1)CC(C(C)(C)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6025","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8-(3-hydroxy-3-methylbutanoyl)-5,7-dimethoxycoumarin
{"Ingredient_id": "HBIN013567","Ingredient_name": "8-(3-hydroxy-3-methylbutanoyl)-5,7-dimethoxycoumarin","Alias": "NA","Ingredient_formula": "C16H18O6","Ingredient_Smile": "NA","Ingredient_weight": "306.31","OB_score": "NA","CAS_id": "75239-74-6","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7412","PubChem_id": "NA","DrugBank_id": "NA"}
[(2r)-2-[(2r)-2-methoxy-5-oxopyrrolidin-1-yl]-2,5-dihydrofuran-3-yl]methyl 1h-pyrrole-2-carboxylate
6-[(1r,2s)-1,2-dihydroxy-3-methylbut-3-en-1-yl]-7,8-dimethoxychromen-2-one
(6s,7r,8as,10as)-1,6,7-trihydroxy-3-methoxy-6-methyl-7,8,8a,10a-tetrahydro-5h-anthracene-9,10-dione
16-chlorohexadeca-13,15-dien-9,11-diyn-3-yl acetate
(2s)-3-hydroxy-1-(7-methoxy-2-oxochromen-8-yl)-3-methylbutan-2-yl formate
(12s,13s)-3,13-dihydroxy-7-methoxy-8-methyl-12-(prop-1-en-2-yl)-4,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-trien-5-one
[(2s)-2-[(2r)-2-methoxy-5-oxopyrrolidin-1-yl]-2,5-dihydrofuran-3-yl]methyl 1h-pyrrole-2-carboxylate
8-hydroxy-1,4,4a-trimethyl-2h,3h-cyclopenta[b]anthracene-5,10-dione
1,6,7-trihydroxy-3-methoxy-6-methyl-7,8,8a,10a-tetrahydro-5h-anthracene-9,10-dione
3,7-dimethyl-7-[2-oxo-2-(2,4,5-trihydroxyphenyl)ethyl]-5,6-dihydrooxepin-2-one
5-{[(2r)-3,3-dimethyloxiran-2-yl]methoxy}-7,8-dimethoxychromen-2-one
(3s,12r,13r)-3,13-dihydroxy-7-methoxy-8-methyl-12-(prop-1-en-2-yl)-4,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-trien-5-one
2-(hydroxymethyl)-6-(naphthalen-1-yloxy)oxane-3,4,5-triol
n-[2-(1h-indol-3-yl)ethyl]-3-phenyloxirane-2-carboximidic acid
[2-(2-methoxy-5-oxopyrrolidin-1-yl)-2,5-dihydrofuran-3-yl]methyl 1h-pyrrole-2-carboxylate
{6,10-dihydroxy-1-methyl-9-oxo-1h,3h,4h,6h,7h,8h-naphtho[2,3-c]pyran-3-yl}acetic acid
2-{7-[(1s)-1-(4-hydroxyphenyl)ethyl]-4-methoxy-1h-indol-3-yl}acetonitrile
3,6,11-trihydroxy-4-methoxy-12-methyl-15-oxatetracyclo[10.2.1.0²,⁷.0⁹,¹⁴]pentadeca-2,4,6-trien-8-one
(1s,2r,4r,10s,11r,14s)-11-hydroxy-10,14-dimethyl-3,6,16-trioxapentacyclo[8.6.1.0²,⁴.0⁴,⁹.0¹⁴,¹⁷]heptadec-8-ene-7,15-dione
4,6-dimethoxy-15-methyl-9,14,16-trioxatetracyclo[8.6.0.0³,⁸.0¹¹,¹⁵]hexadeca-3,5,7-trien-13-one
(9r)-2-methoxy-9-phenyl-8,9-dihydro-7h-phenalene-1,6-diol
(1s,2r,4s,5r,14s,17r)-5-hydroxy-10,14-dimethyl-3,6,16-trioxapentacyclo[8.6.1.0²,⁴.0⁴,⁹.0¹⁴,¹⁷]heptadec-8-ene-7,15-dione
(4ar)-8-hydroxy-1,4,4a-trimethyl-2h,3h-cyclopenta[b]anthracene-5,10-dione
methyl 5-[(acetyloxy)methyl]-7-hydroxy-2,2-dimethylchromene-6-carboxylate
3-hydroxy-1-(7-methoxy-2-oxochromen-8-yl)-3-methylbutan-2-yl formate
3,13-dihydroxy-7-methoxy-8-methyl-12-(prop-1-en-2-yl)-4,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-trien-5-one
(1s,2r,4s,5r,10s,14s,17r)-5-hydroxy-10,14-dimethyl-3,6,16-trioxapentacyclo[8.6.1.0²,⁴.0⁴,⁹.0¹⁴,¹⁷]heptadec-8-ene-7,15-dione
[5-(2-methoxy-5-oxopyrrolidin-1-yl)-2,5-dihydrofuran-3-yl]methyl 1h-pyrrole-2-carboxylate
[(1s,3r)-6,10-dihydroxy-1-methyl-9-oxo-1h,3h,4h,6h,7h,8h-naphtho[2,3-c]pyran-3-yl]acetic acid
(7r)-3,7-dimethyl-7-[2-oxo-2-(2,4,5-trihydroxyphenyl)ethyl]-5,6-dihydrooxepin-2-one
3-(5,7-dimethoxy-2-oxochromen-8-yl)-2,2-dimethylpropanoic acid
6-hydroxy-3',7-dimethoxy-3,5-dimethyl-3,4-dihydrospiro[1-benzopyran-2,2'-furan]-5'-one
(4s)-11,13-dihydroxy-4-methyl-1,4,5,6,8,9-hexahydro-3-benzoxacyclododecine-2,7,10-trione
(4r,8e)-7,11,13-trihydroxy-4-methyl-4,5,6,7-tetrahydro-1h-3-benzoxacyclododecine-2,10-dione
5-hydroxy-3-(2-hydroxypropyl)-6,8-dimethoxy-2-methylnaphthalene-1,4-dione
(1s,5s,6r)-6-(4-hydroxy-3,5-dimethoxyphenyl)-5-(hydroxymethyl)-8-oxabicyclo[3.2.1]oct-3-en-2-one
6-[(1r,2r)-1,2-dihydroxy-3-methylbut-3-en-1-yl]-7,8-dimethoxychromen-2-one
methyl 2-[4-(5-butyl-5-methylfuran-2-ylidene)-3,5-dioxooxolan-2-ylidene]acetate
5-hydroxy-7-methoxy-2-[(1r,4r)-1,4-dihydroxycyclohexyl]chromen-4-one
(4r,8e)-6,11,13-trihydroxy-4-methyl-4,5,6,7-tetrahydro-1h-3-benzoxacyclododecine-2,10-dione
5-hydroxy-10,14-dimethyl-3,6,16-trioxapentacyclo[8.6.1.0²,⁴.0⁴,⁹.0¹⁴,¹⁷]heptadec-8-ene-7,15-dione
5-methoxy-6-methyl-7-[(3-methylbut-2-en-1-yl)oxy]-3-oxo-1h-2-benzofuran-4-carboxylic acid
(5r)-3-hydroxy-5-{1-[(2z)-4-hydroxy-3-methyl-5-oxofuran-2-ylidene]propan-2-yl}-4-methyl-5-[(1e)-prop-1-en-1-yl]furan-2-one
3-(hydroxymethyl)-1,4-dimethyl-3-(methylsulfanyl)-6-(phenylmethylidene)piperazine-2,5-dione
[(5s)-5-[(2s)-2-methoxy-5-oxopyrrolidin-1-yl]-2,5-dihydrofuran-3-yl]methyl 1h-pyrrole-2-carboxylate
(2e)-3-(4-hydroxyphenyl)-n-[2-(1h-indol-2-yl)ethyl]prop-2-enimidic acid
3-[(2s)-2-hydroxy-4-oxopentyl]-6,8-dimethoxyisochromen-1-one
(2z,6e)-2,6-dimethyl-8-oxo-8-(2,4,5-trihydroxyphenyl)octa-2,6-dienoic acid
8-hydroxy-6-[(1r,2s)-2-hydroxy-1-methoxy-3-methylbut-3-en-1-yl]-7-methoxychromen-2-one
(1s,2r,4r,10s,13r,14r)-13-hydroxy-10,14-dimethyl-3,6,16-trioxapentacyclo[8.6.1.0²,⁴.0⁴,⁹.0¹⁴,¹⁷]heptadec-8-ene-7,15-dione
(1r,4'r)-6-ethyl-4',5-dihydroxy-7-methoxy-2,3-dihydrospiro[naphthalene-1,2'-oxolane]-4,5'-dione
2-(2-hydroxypentyl)-7-methoxy-4-oxochromene-5-carboxylic acid
8-methoxy-9-phenyl-2,3-dihydro-1h-phenalene-1,4-diol
(1s,2s)-1-[2-(2,5-dihydroxyphenyl)-2-oxoethyl]-2-hydroxy-3-methylcyclohex-3-ene-1-carboxylic acid
(1s,2r,4s,5s,10s,14s,17r)-5-hydroxy-10,14-dimethyl-3,6,16-trioxapentacyclo[8.6.1.0²,⁴.0⁴,⁹.0¹⁴,¹⁷]heptadec-8-ene-7,15-dione
(2s,3s)-2-[(1s,6r,7r,8s)-1-hydroxy-8-methyl-9-oxabicyclo[4.2.1]nona-2,4-dien-7-yl]-6-oxo-2,3-dihydropyran-3-yl acetate
6-(1,2-dihydroxy-3-methylbut-3-en-1-yl)-7,8-dimethoxychromen-2-one
2-{1-hydroxy-8-methyl-9-oxabicyclo[4.2.1]nona-2,4-dien-7-yl}-6-oxo-2,3-dihydropyran-3-yl acetate
(1s,2s,4s,5s,6r,10s)-10-hydroxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.0²,⁴]decan-5-yl benzoate
(2s,3s)-6-hydroxy-3',7-dimethoxy-3,5-dimethyl-3,4-dihydrospiro[1-benzopyran-2,2'-furan]-5'-one
12-hydroxy-10,14-dimethyl-3,6,16-trioxapentacyclo[8.6.1.0²,⁴.0⁴,⁹.0¹⁴,¹⁷]heptadec-8-ene-7,15-dione
4-{2-oxo-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-3,5,7,9(16),10(15),11,13-heptaen-4-yl}butanoic acid
C18H14N2O3 (306.10043740000003)
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-(naphthalen-1-yloxy)oxane-3,4,5-triol
2-[(8-hydroxynaphthalen-1-yl)oxy]-6-methyloxane-3,4,5-triol
(2r)-8,8-dimethyl-2-phenyl-2h,3h-pyrano[2,3-f]chromen-4-one
methyl 2-{6-methyl-8,12-dioxo-5,11-dioxatricyclo[8.2.1.0⁴,⁶]tridec-1(13)-en-9-ylidene}propanoate
9,10-dihydroxy-5-methoxy-2,8,8-trimethyl-9h,10h-pyrano[2,3-h]chromen-4-one
(3r,4ar,9ar)-4a,7-dihydroxy-3-[(2s)-1-hydroxypropan-2-yl]-1,2,3,9a-tetrahydroxanthene-4,9-dione
1-hydroxy-2-(4-methylpent-3-en-1-yl)anthracene-9,10-dione
6-ethyl-4',5-dihydroxy-7-methoxy-2,3-dihydrospiro[naphthalene-1,2'-oxolane]-4,5'-dione
7-hydroxy-1,4,4a-trimethyl-2h,3h-cyclopenta[b]anthracene-5,10-dione
(4ar)-7-hydroxy-1,4,4a-trimethyl-2h,3h-cyclopenta[b]anthracene-5,10-dione
(2s)-2-amino-4-{[(1r)-1-[(c-hydroxycarbonimidoylmethyl)-c-hydroxycarbonimidoyl]-2-sulfanylethyl]-c-hydroxycarbonimidoyl}butanoic acid
(2s)-5-hydroxy-2-(1-hydroxy-4-oxocyclohexyl)-7-methoxy-2,3-dihydro-1-benzopyran-4-one
(3r,5r,9s)-15,17-dihydroxy-9-methyl-4,10-dioxatricyclo[11.4.0.0³,⁵]heptadeca-1(17),13,15-triene-2,11-dione
(9s,10r)-9,10-dihydroxy-5-methoxy-2,8,8-trimethyl-9h,10h-pyrano[2,3-h]chromen-4-one
1-methyl-2-[(3-methylbut-2-en-1-yl)oxy]anthracene-9,10-dione
methyl 12-methoxy-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,9,11,13,15-octaene-10-carboxylate
C18H14N2O3 (306.10043740000003)
2,6-dimethyl-8-oxo-8-(2,4,5-trihydroxyphenyl)octa-2,6-dienoic acid
6,11,13-trihydroxy-4-methyl-4,5,6,7-tetrahydro-1h-3-benzoxacyclododecine-2,10-dione
3,8,9-trimethyl-3,4-dihydro-2h-1-oxatetraphene-5,12-dione
2-methoxy-9-phenyl-8,9-dihydro-7h-phenalene-1,6-diol
(2s,3r)-n-[2-(1h-indol-3-yl)ethyl]-3-phenyloxirane-2-carboximidic acid
2-hydroxyethyl (2s,5z)-2-isopropyl-4-oxo-5-(phenylmethylidene)-1,3-dioxolane-2-carboxylate
(3s,6e)-3-benzyl-5-hydroxy-1-methyl-6-(phenylmethylidene)-3h-pyrazin-2-one
3-(2-hydroxy-4-oxopentyl)-6,8-dimethoxyisochromen-1-one
(1r,2r)-1-[2-(2,5-dihydroxyphenyl)-2-oxoethyl]-2-hydroxy-3-methylcyclohex-3-ene-1-carboxylic acid
(3r,4ar,9ar)-4a,7-dihydroxy-3-(1-hydroxypropan-2-yl)-1,2,3,9a-tetrahydroxanthene-4,9-dione
(1s,9s,12s)-3-hydroxy-4,6-dimethoxy-12-(2-oxopropyl)-11-oxatricyclo[7.2.1.0²,⁷]dodeca-2,4,6-trien-8-one
7,11,13-trihydroxy-4-methyl-4,5,6,7-tetrahydro-1h-3-benzoxacyclododecine-2,10-dione
3-hydroxy-3-{1-[(2z)-4-hydroxy-3-methyl-5-oxofuran-2-ylidene]propan-2-yl}-4-methyl-5-[(1e)-prop-1-en-1-yl]furan-2-one
methyl 2-[(4r,6s,9z,10s)-6-methyl-8,12-dioxo-5,11-dioxatricyclo[8.2.1.0⁴,⁶]tridec-1(13)-en-9-ylidene]propanoate
7-{[(2r)-3,3-dimethyloxiran-2-yl]methoxy}-6,8-dimethoxychromen-2-one
(2s)-8,8-dimethyl-2-phenyl-2h,3h-pyrano[2,3-f]chromen-4-one
6-ethyl-4-hydroxy-3-[(4-hydroxy-5,6-dimethyl-2-oxopyran-3-yl)methyl]-5-methylpyran-2-one
3-benzyl-1-hydroxy-5-(phenylmethylidene)pyrazine-2,6-dione
C18H14N2O3 (306.10043740000003)
7-[(3,3-dimethyloxiran-2-yl)methoxy]-6,8-dimethoxychromen-2-one
7-(1-hydroxypropyl)-8-methyl-11h-indolizino[1,2-b]quinolin-9-one
(3s,6s)-3-[2-(2,5-dihydroxyphenyl)-2-oxoethyl]-3-hydroxy-6-(prop-1-en-2-yl)oxan-2-one
3-(4-hydroxyphenyl)-n-[2-(1h-indol-2-yl)ethyl]prop-2-enimidic acid
(1r,10r,11r,15r)-4,6-dimethoxy-15-methyl-9,14,16-trioxatetracyclo[8.6.0.0³,⁸.0¹¹,¹⁵]hexadeca-3,5,7-trien-13-one
11,13-dihydroxy-4-methyl-1,4,5,6,8,9-hexahydro-3-benzoxacyclododecine-2,7,10-trione
(9r,11as)-3-(hydroxymethyl)-6-methylidene-2,7-dioxo-4h,5h,8h,9h,11ah-cyclodeca[b]furan-9-yl acetate
3-(4-hydroxyphenyl)-n-[2-(1h-indol-3-yl)ethyl]prop-2-enimidic acid
(3s)-3-benzyl-5-hydroxy-1-methyl-6-(phenylmethylidene)-3h-pyrazin-2-one
(3r,6r)-3-[2-(2,5-dihydroxyphenyl)-2-oxoethyl]-3-hydroxy-6-(prop-1-en-2-yl)oxan-2-one
6-(4-hydroxy-3,5-dimethoxyphenyl)-5-(hydroxymethyl)-8-oxabicyclo[3.2.1]oct-3-en-2-one
8-hydroxy-6-(2-hydroxy-1-methoxy-3-methylbut-3-en-1-yl)-7-methoxychromen-2-one
(2e)-1-(7-hydroxy-2,2-dimethylchromen-6-yl)-3-phenylprop-2-en-1-one
(6r)-6-hydroxy-6-(2-oxopropyl)indolo[2,1-b]quinazolin-12-one
C18H14N2O3 (306.10043740000003)